Vascular Endothelial Growth Factor Receptor Inhibitors in Chinese Patients With Advanced Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Network Meta-Analysis and Cost-Effectiveness Analysis

INTRODUCTION: Two targeted drugs (apatinib and lenvatinib) show clinical efficacy in first-line treatment of Chinese patients with radioactive advanced iodine-refractory differentiated thyroid cancer (RAIR-DTC) and are recommended by the Chinese Society of Clinical Oncology guidelines. Considering t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Youwen, Liu, Kun, Wang, Kailing, Peng, Libo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329872/
https://www.ncbi.nlm.nih.gov/pubmed/35909569
http://dx.doi.org/10.3389/fendo.2022.909333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329872/
https://www.ncbi.nlm.nih.gov/pubmed/35909569
http://dx.doi.org/10.3389/fendo.2022.909333

Ejemplares similares